The gelsolin family of actin regulatory proteins: modular structures, versatile functions  by McGough, Amy M et al.
Minireview
The gelsolin family of actin regulatory proteins: modular structures,
versatile functions
Amy M. McGougha;, Chris J. Staigerb, Jung-Ki Mina, Karen D. Simonettia
aMarkey Center for Structural Biology, Purdue University, West Lafayette, IN 47907-1392, USA
bDepartment of Biological Sciences, the Purdue Motility Group, Purdue University, West Lafayette, IN 47907-1392, USA
Received 16 July 2003; accepted 23 July 2003
First published online 29 August 2003
Edited by Michael R. Bubb
Abstract This issue of FEBS Letters includes two manuscripts
describing structural studies of gelsolin, the best-characterized
member of a superfamily of actin binding proteins that sever,
cap, and in some cases nucleate and bundle actin ¢laments. The
manuscripts by Narayan et al. and Irobi et al. provide snapshots
of gelsolin domains activated by calcium and in complex with
the actin monomer, revealing new insights into the remarkable
actin regulatory activities of this versatile protein. These studies
build upon nearly a quarter of a century of research on gelso-
lin’s e¡ects on actin dynamics and its role in normal and dis-
eased cells. In the following minireview, we summarize the struc-
tural studies that have provided insights into gelsolin’s severing
and capping activities and look to the future of work on this
remarkable molecule.
$ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Gelsolin has multiple actin regulatory activities
Gelsolin was discovered in 1979 by Yin and Stossel based
on its ability to activate the gel^sol transformation of actin
¢laments in a calcium-dependent manner [3]. It occurs in a
wide range of vertebrate, lower eukaryotic and plant cells, and
its function is as varied as its biochemical activities. Indeed,
gelsolin has been implicated in the regulation of cell motility,
in the transduction of signals into dynamic rearrangements of
the cytoskeletal architecture, and even in stimulating pro-
grammed cell death in certain vertebrate cells [4,5].
In the presence of micromolar calcium, gelsolin severs pre-
existing actin ¢laments and caps them, thereby preventing
monomer addition to their fast-growing ends. The barbed
end cap is highly stable, even in the absence of calcium, unless
displaced by interactions with regulatory phospholipids such
as phosphatidylinositol-4,5-bisphosphate (PIP2) [6,7]. In the
presence of a large pool of pro¢lin, or under depolymerizing
conditions, these gelsolin-capped ends allow the disassembly
of populations of actin ¢laments by subunit loss from the
pointed ends [8,9]. Paradoxically, under polymerizing condi-
tions, gelsolin exhibits calcium-dependent actin nucleating ac-
tivity and stimulates actin ¢lament formation from monomers
[10,11]. However, the relevance of the nucleation activity of
gelsolin to its physiological function within cells, whether de
novo, or as the result of uncapping of severed ¢laments, or as
a component of the triggering mechanism for Arp2/3 branch-
ing, remains controversial [12].
2. Gelsolin is a member of a large superfamily of actin binding
proteins
The diverse activities exhibited by gelsolin and its relatives
derive from coordinated movements of homologous, 100^125
amino acid modules that are folded into compact domains.
Gelsolin is composed of six of these domains, termed G1^6
[13], that are connected by linker regions of varying lengths
(Fig. 1A). Early studies of proteolytic fragments of gelsolin
identi¢ed three actin binding regions: a calcium-independent
strong monomer binding fragment (G1), a calcium-indepen-
dent ¢lament binding fragment (G2^3), and a calcium-depen-
dent monomer binding fragment (G4^6) [14]. Subsequent
work established that domains G1 and G4 bind actin mono-
mers, whereas G2 contains ¢lament binding activity. Sequence
analysis reveals that G1 is most closely related to G4, G2 to
G5, and G3 to G6. In addition to cytoplasmic gelsolin, a
secreted form of the protein containing a 25 amino acid
long amino-terminal extension is found in blood plasma
where it appears to play a role in the actin-scavenging system
[15].
Other members of the family such as severin contain three
domains rather than six, yet they retain ¢lament severing,
capping, and nucleating activities, although the latter is weak-
er than that exhibited by full-length gelsolin [16^18]. In addi-
tion to size, severin di¡ers from gelsolin in that it contains a
second ¢lamentous actin (F-actin) binding site in domain 3
[18]. The fact that these shorter forms retain both calcium
sensitivity and nucleating activity, two functions that appear
to derive from the C-terminal half of gelsolin, raises questions
about the role of domains G4^6. Selden and colleagues have
reported that the severing e⁄ciency of gelsolin G1^3 is con-
centration dependent, suggesting that cooperativity between
the N- and C-terminal halves of gelsolin is required for full
e⁄ciency [19]. Interestingly, the other well-studied class of
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actin ¢lament severing proteins, the actin depolymerizing fac-
tor (ADF)/co¢lins, also bind cooperatively and require multi-
ple binding events for severing to occur, although in other
respects these proteins di¡er quite dramatically from gelsolin
[20,21].
In addition to the array of gelsolin-related severing pro-
teins, variations of the basic gelsolin six- or three-repeat struc-
ture are found in molecules that possess somewhat di¡erent
sets of actin regulatory activities. Addition of a small C-ter-
minal F-actin binding ‘headpiece’ domain converts a gelsolin-
like molecule into a bundling protein, termed ‘villin’ based on
its localization in microvilli [22,23]. And, substitution of a
handful of residues in domain G1 appears to be key for dis-
tinguishing an actin ¢lament capping factor, CapG, from a
severing protein [24]. Further variations of gelsolin and re-
lated proteins continue to be identi¢ed. In most cases, these
molecules possess additional domains that tailor their expres-
sion, localization, and regulation to the appropriate regions of
motile cells (reviewed in [25]). Taken together, these diverse
activities make the gelsolin superfamily one of the most ver-
satile regulators of actin’s function in cells.
3. Molecular snapshots of severing
The holy grail of the gelsolin ¢eld is a molecular movie of
this dynamic molecule as it undergoes large-scale conforma-
tional changes during calcium activation, binding, severing,
capping, and uncapping. The di⁄culties in achieving this
goal reside in the speed with which gelsolin severs, the multi-
plicity of steps in the reaction, the relatively small size of
gelsolin, the number of actin subunits involved, and the in-
herently dynamic nature of the actin ¢lament itself. Never-
theless, signi¢cant progress in developing such a movie has
been made over the past 15 years. Some of the key structural
Fig. 1. Domain organization with references to structures determined. A: Residues have been numbered according to domains of human plas-
ma gelsolin as described in [26]. 2 indicates the location of the C188^C201 disul¢de bond of plasma gelsolin [74]. B: Quick reference for struc-
tural data on gelsolin. Residues listed are those visible in the respective X-ray or NMR models numbered according to plasma gelsolin. Data
are from [1,2,26,31,33,34,36,41,42,64,68,70^73]. C: References for other key members of the gelsolin family of proteins. Abbreviations: MS,
mass spectroscopy; CD, circular dichroism; NMR, nuclear magnetic resonance; and FAF, familial amyloidosis-Finnish type. Data are from
[24,48,75,76].
FEBS 27620 11-9-03 Cyaan Magenta Geel Zwart
A.M. McGough et al./FEBS Letters 552 (2003) 75^8176
snapshots that have come into focus in recent years are de-
scribed below (summarized in Fig. 1B,C).
3.1. Crystal structure of full-length gelsolin in EGTA: inactive
gelsolin is ‘latched’ shut
A major leap forward was achieved with the determination
of the structure of the full-length molecule by X-ray crystal-
lography [26]. In addition to con¢rming the structural simi-
larity of the six domains of gelsolin, this structure suggests
how the arrangement of these domains in the absence of cal-
cium leads to inactivation. One striking feature of the model is
the appearance of a so-called ‘latch helix’ at the C-terminus
that blocks the putative actin binding site in domain 2. The
importance of this helix in calcium regulation was revealed,
long before its existence was known, by deletion studies in
which removal of the V20 C-terminal residues in gelsolin
eliminated calcium regulation [4,27]. Also signi¢cant is the
presence of a large 53-residue linker between the N- and
C-terminal halves of the molecule that is presumably neces-
sary for gelsolin’s C-terminal half to reach its binding site
when the N-terminal half is bound to the ¢lament.
3.2. X-ray structures of G4^6, radiolytic footprinting of active
gelsolin: calcium activation triggers large domain
movements
Thus far, the high-resolution structure of calcium-activated
gelsolin has remained elusive in part because the large-scale
conformational changes that occur during activation would
disrupt gelsolin crystals obtained in EGTA if soaked in cal-
cium [28^30]. Nevertheless, crystal structures of G4^6 acti-
vated by calcium both on its own [1,31] and bound to actin
[32,33] reveal large conformational changes in the C-terminal
half of the molecule and suggest, by analogy, that similar
changes might occur in G1^3.
Additional insights into the conformational changes that
accompany calcium activation have derived from recent radio-
lytic protein footprinting analysis (a method in which syn-
chrotron irradiation is used to modify solvent-accessible re-
gions of proteins) [34]. These studies point to residues that are
buried in the EGTA form of gelsolin [26], but become exposed
upon binding calcium. The exposed residues are distributed
throughout ¢ve peptides: 49^72 (G1), 121^135 (G1), 162^166
(G2), 431^454 (G4), and 722^748 (C-terminal ‘latch’ helix).
Other peptides in domains G3 (276^300) and G6 (652^686)
become less accessible as the domains move relative to one
another. The dose responsiveness of gelsolin to calcium sug-
gests a three-state transition, with major activation occurring
at concentrations of calcium below 100 nM, and followed by
actin binding at micromolar levels [34,35]. This means that it
is doubtful that a single crystal structure of calcium-activated
gelsolin will be su⁄cient to address all aspects of the severing
mechanism.
3.3. Electron cryomicroscopy of G2^6:F-actin in calcium: G2
binds two actin subunits when targeting ¢laments during
severing
Although no atomic structure yet exists of gelsolin targeting
F-actin, a low-resolution ‘snapshot’ of the third step in sever-
ing was obtained by electron cryomicroscopy [36]. In these
studies, a truncated form of gelsolin with calcium-activated
severing activity, G2^6, was imaged in association with F-ac-
tin and a three-dimensional reconstruction calculated toV3.5
nm resolution. Di¡erence mapping revealed that the G2^6
molecule had two major regions that exhibited di¡erent struc-
tural properties. The F-actin binding region (presumably G2^
3) was statistically well determined, consistent with its place-
ment at low radius ¢rmly attached to two longitudinally as-
sociated actin subunits on the ¢lament. The second mass at
high radius in the structure (presumably G4^6) was relatively
weak and poorly determined. One explanation for this is that
the G2^6 molecules were trapped at di¡erent conformational
states during severing resulting in a ‘smeared’ snapshot of the
moving molecules. Time-resolved electron cryomicroscopy
[37] of G2^6 molecules frozen at di¡erent moments in time
following calcium activation should help to resolve this ques-
tion.
Interestingly, electron microscopy (EM) has also shown
that ¢laments are kinked in the presence of activated G2^6,
but not when decorated with EGTA-bound G2^6 or by G2^3
[36,38,39]. This observation is consistent with video microsco-
py images in which ¢laments are seen to distort and kink
during ¢lament severing by gelsolin [40]. Crystal structures
of cross-linked actin oligomers bound with gelsolin G1 also
show a distorted ‘¢lament’ structure leading some to speculate
that distortion by twisting might accompany severing [41] in a
manner reminiscent of co¢lin [20]. Whether or not ¢lament
distortion of the £exible actin ¢lament is actively induced
during severing or merely exploited by gelsolin (or perhaps
required by a truncated form like G2^6 that lacks the strong
monomer binding domain) remains to be seen.
3.4. Co-crystals of G1 with actin monomer: G1 binds the
‘barbed’ end of actin, disrupting ¢lament interactions
There have been a number of crystal and nuclear magnetic
resonance (NMR) structures of domain G1, both on its own
and in complex with actin. Gelsolin domain G1 has proven to
be an e¡ective tool for studying actin monomer structure ow-
ing to its high-a⁄nity binding site on actin away from the
adenosine triphosphate (ATP) binding loop. In the interest
of space, we will discuss only one of the structures here.
Because G1 on its own binds actin monomers and prevents
actin polymerization, the G1:actin complex could be crystal-
lized and its structure determined by X-ray crystallography
[42]. In addition to providing the ¢rst molecular picture of
the gelsolin fold, this study shows that domain G1 binds
near the barbed end of the actin molecule in a cleft between
actin subdomains 1 and 3. This site overlaps, but is distinct
from, the binding site for pro¢lin, a monomer binding protein
that binds at the barbed end surface of actin [43]. Comparison
of G1’s binding ‘footprint’ on the surface of actin to those
identi¢ed for gelsolin G2 and co¢lin by electron cryomicro-
scopy reveals striking similarities (¢g. 5 in [44]). The main
di¡erences (aside from those attributable to di¡erences in res-
olution) are the involvement of a second surface of actin (sit-
uated on subdomains 1 and 2) in the F-actin binding proteins’
footprints and the involvement of the Glu167-containing
‘loop’ in actin subdomain 3 in both the gelsolin G1 and pro-
¢lin binding sites. The latter may be signi¢cant since this loop
appears to participate in an important actin^actin contact
predicted by the Lorenz model of the actin ¢lament [45,46].
3.5. Co-crystals of G4^6 with actin monomer: G4 binding
resembles G1
Another important structure that has been determined by
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X-ray crystallography is the G4^6:actin complex [32,33].
Although the locations of the strong calcium-independent
monomer and the ¢lament binding domains were identi¢ed
relatively early in gelsolin studies, the identi¢cation of the
second monomer binding domain remained elusive owing to
di⁄culties in expressing functional G4, G5, and G6 domains.
This issue was resolved when the G4^6:actin structure re-
vealed that G4 binds actin in a manner analogous to G1.
Comparison of calcium-activated G4^6:actin and G4^6 with
each other and with the EGTA form of gelsolin reveals that
actin is not required for activation and shows how calcium
binding produced rearrangements between domains.
3.6. Combining X-ray, NMR, and EM structures: models of
¢lament capping by gelsolin
It will be challenging to determine the structure of the
capped ¢lament directly. Thus far it has proven di⁄cult to
obtain crystals of F-actin for X-ray crystallography; and the
small size of the capped end (V130^170 kDa for two to three
actin subunits plus one G1^3; V175^215 kDa for two to
three actin subunits plus gelsolin) and lack of internal sym-
metry hinders structure determination by electron cryomicro-
scopy. Nevertheless, reasonable models of ¢lament capping
have been put forth by combining structures obtained with
X-ray crystallography, EM, and NMR spectroscopy in the
context of biochemical data (Fig. 2).
3.6.1. Positioning domains G1^3 in the capped ¢la-
ment. There is general agreement that when domains G1^3
are bound to ¢laments following severing they interact with
two actin subunits, consistent with binding studies of the iso-
lated domains [47]. Crystallography has shown how G1 inter-
acts with the actin monomer, but for several years there was
debate about the placement of the F-actin binding domain,
G2, both on the actin ¢lament and relative to G1 [42,47^49].
The most widely agreed-upon model places G2 on the outer
domain of actin bridging actin subunit 1, the same subunit to
which G1 is bound, and subunit 3, the next subunit running
towards the pointed end along the long-pitch helix of actin
(see Fig. 2, both panels) [36,39,47,49]. This binding model for
G2 explains why the F-actin binding domain of alpha-actinin,
KA1-2, can substitute for G2^3 in a hybrid molecule that
possesses ¢lament severing activity [50,51].
Additional insights into the structure of the G1^3 cap are
provided in this issue of FEBS Letters. Irobi and colleagues
extended the analysis of G1:actin interactions by co-crystal-
lizing actin with G1+, a gelsolin construct containing G1^G2
linker residues [2]. In previous biochemical studies these linker
residues conferred severing activity on domain G1 suggesting
they possess actin binding activity [2,4]. The structure by Irobi
and colleagues shows the placement of the G1^G2 linker on
the surface of actin and provides support for the models of
G1^2:F-actin interactions in which G1 and G2 are bound to
adjacent subunits on the same long-pitch helix of the ¢lament
[36,39,47,49,50,52].
3.6.2. Positioning domains G4^6 in the capped ¢la-
ment. The placement of the C-terminal half of gelsolin in
the capped ¢lament is less well understood. First, there is
debate concerning how many actin subunits are involved in
the capped end with some studies suggesting two [11,47] and
others suggesting three actin subunits are bound to gelsolin in
the complex [53]. For simplicity’s sake, we will present models
of ¢laments capped by gelsolin assuming that all three actin
binding domains (G1, G2, and G4) remain bound to actin in
the cap. Second, although crystallographic studies have shown
how the C-terminal half of gelsolin (G4^6) binds actin mono-
mers, it is still not clear to which actin subunit in the ¢lament
G4 is bound.
There appears to be general consensus that gelsolin reaches
across the ¢lament axis, placing G4 on the adjacent long-pitch
strand (gray strand in Fig. 2). Most models place G4 on sub-
Fig. 2. Two possible modes of ¢lament capping. In both models G1
(blue-violet domain; PDB 1EQY) is docked onto the terminal actin
(subunit 1, yellow strand) according to the co-crystal structure of
McLaughlin et al. [42]. G2 (pink domain; PDB 1D0N) was aligned
to the gelsolin portion of the G1:actin structure on subunit 3 using
the same strategy as Puius et al. [52] and consistent with the elec-
tron cryomicroscopy data of McGough et al. [36]. The adjacent do-
main G3 (green) was displayed following alignment based on the
structure of full-length EGTA-bound gelsolin. Note: aligning G2^3
in this way only provides an approximation of this domain’s posi-
tion on F-actin as it leads to steric clashes with the lower actin sub-
unit. A: Placing the G4^6:actin structure (PDB 1H1V) on subunit 2
of the ¢lament requires that the G3^G4 linker spans a distance of
V100 AT . B: In the alternative model, G4 binding to actin subunit 4
requires the linker to span a distance of V75 AT . (Note: in both
instances the shortest route bisects actin subunits.) The C-terminus
of domain G3 is indicated with a red asterisk. The N-terminus of
domain G4 is indicated with a blue asterisk. Actin ¢laments are rep-
resented by space-¢lling models oriented with the minus or slow-
growing end up. Actin subunits from one long-pitch ‘strand’ are
colored yellow and those from the other are colored gray. Gelsolin
domains are colored according to the scheme used in Fig. 1 as fol-
lows: G1=blue-violet, G2=pink, G3=green, G4=aqua, G5= red,
and G6= lime green. Both models are shown in side-by-side stereo.
Molecular models were generated with the program O [69] and ren-
dered with the program VMD [70].
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unit 2, adjacent to subunit 1 along the short-pitched helix
(Fig. 2A). Assuming G2 binds actin subunit 2 in a similar
position as G1 on subunit 1 [36,52] and that there is no large
conformational change in G2^3 when activated by calcium,
the distance between the C-terminus of domain G3 and the
N-terminus of G4 on subunit 2 is about 100 AT . Alternatively,
if G4 binds actin subunit 4, the distance that must be spanned
by the 53-residue G3^G4 linker is much shorter (V75 AT ; Fig.
2B). It is important to bear in mind, however, that it is pos-
sible that actin’s £exibility is exploited in the formation of the
cap [54^57], in which case the distance between domains G3
and G4 could be very di¡erent in the capped ¢lament.
The only direct evidence concerning the positioning of G4^
6 during severing suggests that the C-terminal half reaches
across the ‘front’ of the actin ¢lament (closest to the viewer
in Fig. 2), rather than across the back [36]. As a result of
actin’s helical symmetry, subunit 4 would then be rotated
towards the C-terminal half (relative to the orientation of
subunit 2). According to this scheme, the actin ¢lament
capped by gelsolin would have a ‘jagged’ barbed end owing
to the absence of subunit 2. It is not known if actin can adopt
this rather unusual con¢guration of actin subunits at its end.
However, a number of EM studies have shown what appear
to be independently stable strands of actin at ¢lament ends
under a variety of conditions suggesting that a ‘jagged’ barbed
end is possible, particularly if stabilized by multiple contacts
with an actin binding protein as has been shown for co¢lin
[58^61].
Fig. 3. Schematic of gelsolin severing mechanism. In this schematic the actin ¢lament is represented by a space-¢lling model oriented with its
slow-growing or minus end up. Actin subunits from one long-pitch ‘strand’ are colored yellow (subunits 1, 3, 5) and those from the other are
colored gray (subunits 2, 4, 6). The actin ¢lament can also be described by the so-called ‘genetic helix’ which runs in a left-handed sense from
the plus towards the minus end of the ¢lament through subunits 1, 2, 3, 4, 5, etc. Gelsolin is represented schematically as six domains (circles,
G1^G6) connected by linkers of varying lengths. In EGTA, gelsolin is a compact structure with potential actin binding sites masked by interdo-
main associations and the C-terminal ‘latch helix’. I: According to the scheme of Kolappan et al. ([31]) upon binding of calcium to G6, salt
bridges between G2 and G6 are broken and the C-terminal latch helix is released, exposing the F-actin binding site of G2. Binding of calcium
to G5 stimulates further movements that complete activation. The conformation of G1^3 during the activation is unknown. II: The activated
gelsolin undergoes a conformational change, allowing G2 to bind to two longitudinally associated actin subunits (labeled 1 and 3 on this dia-
gram) which fall on one of the two long-pitch helical strands. Possible type-2 calcium binding sites are shown (solid gray circles); however, the
order of calcium binding is not known. III: After binding of G2 to F-actin, G1 is directed to its actin binding site. Type-1 calcium is known
to exist at the G1 and G4 actin interfaces (open pink boxes) and binds to G1 and G4 in the presence of actin (solid pink boxes). IV^V: Sever-
ing and capping proceeds through binding of G4 to an actin subunit on the adjacent long-pitched strand, most likely either actin 2 (Va) or 4
(Vb). (Actin residues that could potentially bind G4 are indicated with dark balls on actin subunits from the gray strand.) Gelsolin remains
bound after severing actin, functioning as cap and preventing actin monomers from being added to the ¢lament. Most models of ¢lament se-
vering and capping place G4 on actin subunit 2 (VIa), but the binding site on actin subunit 4 (VIb) is also close enough to permit G4 binding
owing to the helical symmetry of the ¢lament. VI^VII: Binding of PIP2 to the region between G1 and G2 releases gelsolin from actin, freeing
the barbed end for polymerization. The details of uncapping are not known but may involve conformational changes in the linker between do-
mains G1 and G2. Actin molecules were rendered with the program VMD [70].
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4. Gelsolin undergoes coordinated movements of homologous
domains during severing
The structural studies summarized above, coupled with a
wealth of biochemical and biophysical data, have led to a
generally agreed-upon scheme for the gelsolin severing mech-
anism depicted schematically in Fig. 3. Although this scheme
is far from complete, it serves as a useful discussion point for
interpreting new data and guiding future experiments.
4.1. Calcium activation
The ¢rst step in severing is activation by calcium (Fig. 3,
step I). Recent evidence suggests that this is a three-state pro-
cess involving two types of calcium ions, type-1 and type-2.
(Type-1 calcium sites involve coordination between gelsolin
and actin residues, whereas type-2 calcium sites consist solely
of gelsolin residues [33].) At submicromolar concentrations,
calcium occupation of type-2 sites of domains G5 and G6
leads to the release of a so-called ‘latch’ helix at state 2, which
masks the F-actin binding domain G2 in the absence of cal-
cium [26,34]. In order for severing to occur, higher concen-
trations of the ion are required (10 WM for half-maximal
activity in vitro [62]). Additional calcium binding, most likely
to domains G1, G2 and G4, provides full activation through
saturation of the molecule, thus allowing actin binding and
severing to take place. In total there appear to be eight po-
tential calcium binding sites on gelsolin, two type-1 and six
type-2, although it is not clear that all are ever occupied [33].
4.2. Filament binding
Following activation and release from the latch, the F-actin
binding domain (G2) is exposed, permitting ¢lament targeting
(Fig. 3, step II). In so doing G2 brings G1, the strong calci-
um-independent monomer binding domain, in proximity to its
binding site on the actin ¢lament. Recent evidence suggests
that there may be some additional structural changes in G2
upon calcium activation [63,64], although G2 on its own (or
as part of G2^3 or G2^6) can bind F-actin in the absence of
calcium [14,38,51].
4.3. Filament severing
After binding, gelsolin rapidly severs F-actin. To do this G1
must insert itself between two longitudinally associated actin
subunits along one of the long-pitch strands in the ¢lament
(Fig. 3, step III). Interestingly, both severin and gelsolin G1^3
can sever about as e⁄ciently as full-length gelsolin [4,17,
38,65]. Thus, it appears that disruption of the longitudinal
actin^actin bonds along one ¢lament strand is su⁄cient to
permit severing even though there are additional actin^actin
bonds on the adjacent F-actin strand that would appear to be
undisrupted when G1 binds. Interestingly, ¢laments decorated
by the actin severing protein co¢lin show single-stranded
breaks along their lengths [61], although more work is needed
to determine if these breaks represent intermediate steps in
co¢lin’s severing mechanism.
4.4. Filament capping and uncapping
Presumably the actin ¢lament capped by full-length gelsolin
would also involve interactions of domain G4 of gelsolin and
a barbed end subunit on the actin ¢lament, although it is still
not known which actin subunit is bound by G4 (Fig. 3, steps
IV^V; compare pathways a and b). It has been suggested that
each gelsolin contacts three actin subunits of F-actin during
severing but only two of those remain bound in the capped
¢lament [47]. This cap can be removed by speci¢c interactions
between the N-terminal half of gelsolin and polyphosphoino-
sitides (PPIs) at sites near the G1^G2 interface (Fig. 3, steps
VI^VII). Two formal possibilities exist for the disruption of
the gelsolin cap by PPI binding [66]. One involves competition
for binding sites much as is thought to occur with other PPI-
regulated actin binding proteins. Alternatively, PPIs may alter
the conformation of the G1^G2 linker, destabilizing the cap in
the process [39,67,68].
5. Concluding remarks
Great strides have been made in understanding the molec-
ular mechanism that gelsolin uses to bind, sever, and cap
¢laments using a combination of structural biology, biophy-
sics, biochemistry, genetics and molecular modeling since its
discovery nearly a quarter of a century ago. X-ray crystallog-
raphy has provided the most detailed pictures of gelsolin’s
inter- and intramolecular interactions; whereas NMR spec-
troscopy, X-ray footprinting, electron cryomicroscopy, and
molecular modeling give insights into the dynamic changes
gelsolin undergoes during activation, severing, and uncapping.
Thus, it seems likely that producing a molecular movie of
¢lament severing by gelsolin will require a combined approach
in which high-resolution snapshots determined by X-ray crys-
tallography are ¢t together in space and time using other
biophysical methods, much as has proven to be the case for
the study of the molecular motor myosin.
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